Maurice Zandvliet

8PUBLICATIONS
25CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 30, 2025
Evaluating VEGFR2 as a Target for Anti-Tumour Therapy in Canine Melanoma.

Esther Hindriks, Wilhelmina Bergmann, Aitor Martínez Ruiz

|Sep 03, 2025
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma.

Marit F van den Berg, Aitor Martínez Ruiz, Maurice M J M Zandvliet

|Apr 09, 2025
Rational design of alternative treatment options for radioresistant rectal cancer using patient-derived organoids.

D Andel, A J Nouwens, S Klaassen

|Oct 02, 2024
Tuft cells act as regenerative stem cells in the human intestine.

Lulu Huang, Jochem H Bernink, Amir Giladi

|Aug 26, 2023
Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands.

Hannah Versteegh, Maurice M J M Zandvliet, Laurien R Feenstra

|Apr 28, 2023
Ultrasound and Microbubbles Mediated Bleomycin Delivery in Feline Oral Squamous Cell Carcinoma-An In Vivo Veterinary Study.

Josanne S de Maar, Maurice M J M Zandvliet, Stefanie Veraa

Pageof 2

Frequent Collaborators

2 joint publications

Onno Kranenburg

2 joint publications

Francine van der Steen

1 joint publications

D Andel

1 joint publications

Else Driehuis